First Ebola vaccine trial launches in Democratic Republic of Congo outbreak

Source Summary

The first clinical trial of an Ebola vaccine in the ongoing outbreak in the Democratic Republic of Congo began Friday, according to the World Health Organization director. The trial represents an immediate intervention to test vaccine efficacy during an active epidemic.

Why it matters

Vaccine trials during active outbreaks can provide direct evidence of protection and accelerate deployment of countermeasures to control disease spread.